Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG) (Q33347913)
Jump to navigation
Jump to search
scientific article published on May 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG) |
scientific article published on May 1, 2003 |
Statements
1 reference
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG) (English)
1 reference
1 reference
EORTC Early Clinical Study Group
1 reference
C. Terret
S. Zanetta
H. Roché
J. H M. Schellens
M. N. Faber
J. Wanders
M. Ravic
1 May 2003
1 reference
1 reference
1 reference
39
1 reference
1097-1104
1 reference
Identifiers
1 reference
1 reference